AC Immune (ACIU) is Initiated by Leerink Partners to Outperform

AC Immune (ACIU) was Initiated by Leerink Partners to “Outperform”. Leerink Partners advised their investors in a research report released on Oct 18, 2016.

Many Wall Street Analysts have commented on AC Immune. Credit Suisse Initiated AC Immune on Oct 18, 2016 to “Outperform”, Price Target of the shares are set at $18.Jefferies Initiated AC Immune on Oct 18, 2016 to “Buy”, Price Target of the shares are set at $25.

AC Immune

Leave a Reply

AC Immune - Is it time to Sell?

Top Brokerage Firms are advising their investors on AC Immune. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.